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Edited by Amy McGoughAbstract Cortactin is an important molecular scaﬀold for actin
assembly and organization. Novel mechanistic functions of cort-
actin have emerged with more interacting partners identiﬁed,
revealing its multifaceted roles in regulating actin cytoskeletal
networks that are necessary for endocytosis, cell migration and
invasion, adhesion, synaptic organization and cell morphogene-
sis. These processes are mediated by its multi-domains binding
to F-actin and Arp2/3 complex and various SH3 targets. Fur-
thermore, its role in actin remodeling is subjected to regulation
by tyrosine and serine/threonine kinases. Elucidating the mecha-
nisms underlying cortactin phosphorylation and its functional
consequences would provide new insights to various aspects of
cell dynamics control.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Actin cytoskeleton1. Introduction
Cell dynamics is inﬂuenced by both external and internal
cues that exert their eﬀects by precise coordination of various
signal transduction cascades linking to intricate cytoskeleton
networks. This requires the activation and inactivation of mul-
tiple actin and microtubules modiﬁers, kinases, guanine nucle-
otide triphosphatases (GTPases) and their various eﬀectors
and regulators [1]. Cortactin has emerged as an imperative
molecular scaﬀold that mediates the assembly and organiza-
tion of actin cytoskeletal matrices leading to various aspects
of cell dynamics. The characterization and cellular functions
of cortactin in actin dynamics have been extensively reviewed
elsewhere [2,3]. Since its ﬁrst identiﬁcation as a substrate of
v-Src [4], various kinases have also been reported to act upon
cortactin. Here, we will discuss how phosphorylation by dis-
tinctive kinases could aﬀect the biochemical and cellular func-
tions of cortactin for the molecular assembly associated with
actin remodeling and cell dynamics control.*Corresponding author. Fax: +65 6779 2486.
E-mail address: dbslowbc@nus.edu.sg (B.C. Low).
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Cortactin consists of an N-terminal acidic (NTA) domain
and six-and-a half tandem repeats (cortactin repeats) at its
N-terminus, followed by an a-helix, a proline-rich region
(PRR) and a Src Homology-3 (SH3) domain at its C-terminus
(refer to Fig. 2B for a schematic diagram). It is normally ex-
pressed ubiquitously but is believed to be involved in various
human diseases either through gene ampliﬁcation (e.g., in
breast cancer) [5], overexpression of its mRNA (e.g., in bladder
tumors [6] and hepatocellular carcinoma [7]) or by interacting
with speciﬁc targets such as Faciogenital Dysplasia protein-1
(Fgd1) [8].
Several cortactin isoforms exist with varying cortactin re-
peats while retaining the conserved C-terminus. They display
diﬀerential expression proﬁles and varying binding capacity
to ﬁlamentous (F)-actin [9,10]. The fourth cortactin repeat
being the absolute requirement for F-actin binding while the
third and ﬁfth repeats are needed for eﬃcient binding [11].
F-actin is formed by reversible polymerization of globular
(G)-actin and it provides the structural framework and
mechanical force to drive morphological changes. This process
is driven by actin-related protein (Arp)2/3 complex which is
activated by nucleation promoting factors (NPFs) such as
Neuronal-Wiskott–Aldrich Syndrome protein (N-WASP) that
recruits G-actin monomer to the site of polymerization [12].
Although cortactin cannot bind G-actin, it can activate
Arp2/3 weakly [13] and this action can be synergized with N-
WASP via one of the two possible mechanisms.
First, the activation of Arp2/3 complex via the NTA domain
of cortactin requires the binding of F-actin to the cortactin re-
peats. In addition to its ability to stimulate Arp2/3 complex, it
plays a role in stabilization of ﬁlament branch points and inhi-
bition of debranching and disassembly of actin [14]. At the
branch site, (i) a ternary complex might form after cortactin
has displaced the initial binding of verprolin homology, coﬁlin
homology and acidic (VCA) domain of N-WASP to Arp3. In
this complex consisting of Arp2/3-WASP-cortactin, the NTA
domain of cortactin interacts with Arp3 subunits of Arp2/3
complex while the N-WASP VCA associates with Arp2 and
ARPC1 (one of the other ﬁve polypeptides) [15], or (ii) cortac-
tin can completely displace N-WASP after it has acquired a
higher aﬃnity for the activated Arp2/3 complex [16].
Second, the SH3 domain of cortactin binds to the PRR of
N-WASP [17,18] and synergizes the nucleation activity of
Arp2/3 complex by simultaneous binding of its NTA domainblished by Elsevier B.V. All rights reserved.
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a stable complex. This interaction is diﬀerentially regulated by
Erk and Src kinases [18] and constitutes a novel mechanism of
cortactin action in actin dynamics (see later in Section 4 and
Fig. 2). Interestingly, the SH3 domain of cortactin also inter-
acts with another regulator of WASP, the WASP-interacting
protein (WIP) at its PRR [19] that also recognizes the Ena
VASP Homology (EVH) domain of N-WASP [20,21]. WIP
which contains a G-actin-binding module could enhance cort-
actin-Arp2/3-mediated actin polymerization by facilitating the
incorporation of G-actin into the growing actin ﬁlaments. It is
therefore possible that all three form a cortactin-WASP-WIP
ternary complex to regulate the Arp2/3 activity [18]. These
ﬁndings highlight the versatility of cortactin in regulating actin
dynamics that can be ﬁne-tuned by coupling to diverse targets
and subjected to phosphorylation as discussed below.3. Linking cortactin phosphorylation to its role as a molecular
scaﬀold for cell dynamics control
While the NTA domain and cortactin repeats are directly en-
gaged in actin assembly, the PRR and SH3 domain of cortac-
tin serve to modify its biochemical properties and diversify its
cellular functions by acting as targets for phosphorylation and
speciﬁc cellular factors, respectively. Some of the SH3 targets
include GTPase (dynamin2) [22], GTPase regulators (e.g.,
BPGAP1, a Rho GTPase-activating protein [23] and Fgd1, aFig. 1. Cortactin regulates various aspects of cell dynamics. Modular interac
complexes to regulate actin organization and cellular features as depicted in
adhesion through the formation of adherens and tight junction [26,36,78], neu
epithelial or ﬁbroblast cell migration and morphogenesis [8,23,28–32] as well
status of cortactin phosphorylation mediated mainly by the Src or Fyn tyrosi
established. Abbreviations used: PSD, post-synaptic density; IPR3, Inositol
receptor; CIRL1, calcium-independent receptors for latrotoxin/a-lactroto
receptors, metabotropic glutamate receptors; EGF, epidermal growth factor;
CD2-associated protein; CortBP1, cortactin binding protein 1; ZO-1, zonnu
Heparin-binding growth-associated molecule; HA/CD44, Hyaluronan/CD44Cdc42 guanine nucleotide exchange factor [8]), other adap-
tors/scaﬀolds (CD2AP [24], CortBP1 [25], ZO-1 [26], and
WIP [19]), and NPFs (N-WASP) [17,18]. They provide impor-
tant insights to the diverse roles of cortactin-based actin cyto-
skeletal network in endocytosis, cell migration and invasion,
adhesion, synaptic organization and cell morphogenesis (Fig.
1).
Protein phosphorylation serves as a major switch for
many cellular signaling events. It could act as a switch to
regulate conformation of a protein, thus modifying its cellu-
lar and biochemical properties or/and serves as a signature
to recruit other proteins to its close proximity [27]. Cortactin
was originally identiﬁed as a major substrate of the v-Src
tyrosine kinase [4]. To date, diﬀerent kinases, mostly growth
factor receptor tyrosine kinases and non-receptor tyrosine
kinases and several serine/threonine kinases, can either di-
rectly or indirectly lead to cortactin phosphorylation in vitro
or in vivo. While exactly how cortactin phosphorylation
would inﬂuence its ultimate cellular functions still remains
largely unknown, its potential mechanistic function could
be assessed by examining (i) when and how it gets phos-
phorylated and targeted to, including its disposition before
and after phosphorylation, (ii) how it would aﬀect the F-
actin assembly, (iii) its inﬂuence on its binding capacity to
various partners, and/or (iv) eﬀects of its phosphorylation
or lack of phosphorylation on the cellular process in ques-
tions. Indeed, cortactin phosphorylation occurs in response
to various cellular conditions (Table 1).tions of cortactin allow its direct engagement with multiple partners or
a typical cell model. These include podosomes formation [34,52], cell
ronal morphogenesis and diﬀerentiation [25,37–39], axon guidance [40],
as endocytosis [22,24]. Some of these processes can be regulated by the
ne kinases, whereas such requirement in other pathways have yet to be
trisphosphate receptor 3; SSTR2, transmembrane type 2 somatostatin
xin receptor CL1; NMDAR, N-methyl-D-aspartate receptor; mGlu
FGF, ﬁbroblast growth factor; Fgd1, Faciogenital dysplasia 1; CD2AP,
la occludens 1; ICAM-1, intercellular adhesion molecule 1; HB-GAM,
(Hyaluronan receptor).
Table 1
Cortactin phosphorylation in diverse cellular conditions, stimulated during physiological, pathogenic as well as pharmacological conditions
Stimuli Implicated kinase Reference
Physiological Oncogenic transformation with v-Src Src [4]
Thrombin-induced platelet aggregation Src [67]
Integrin-mediated cell adhesion Src [68]
Hydrogen peroxide-mediated injury of endothelial cells Src [69]
Heparin-binding growth-associated molecule-mediated neurite outgrowth Src [37]
Podosomes formation in v-Src transformed cells Src [34]
Fibroblast growth factor 1-mediated cell migration Src [29]
Hyaluronic acid/CD44(Hyaluronan receptor)-mediated ovarian tumor migration Src [31]
Epidermal growth factor Src, Erk [70,59]
Thromboxane-induced platelet morphology changes Syk [71]
Hepatocyte growth factor METa [72]
Calcium-mediated keratinocyte diﬀerentiation Fer [73]
Platelet-derived growth factor Fer [47]
Hypertonicity/osmotic stress Fyn, Fer [74,75]
Integrin-mediated melanoma cell migration Fyn [32]
Sphingosine 1-phosphate-mediated endothelial cell remodeling MLCKa,b [46]
Thrombin-activated lamellipodial spreading of platelet PAKa [42]
Hyaluronan/CD44-mediated keratinocyte adhesion and diﬀerentiation. PKNca [43]
Pathogenic Shigella ﬂexneri invasion Src [76]
Cryptosporidium invasion Src [33]
Pharmacological Cytochalasin D (actin depolymerization agent) Src [63,77]
Latrunculin B (actin depolymerization agent) Fyn/Fer [62]
Jasplakinolide (F-actin stabilization drug) Fyn/Fer [62]
aPhosphorylation site(s) not deﬁned.
bAbility to directly phosphorylate cortactin is still unknown.
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by the strong positive correlation between its high level of tyro-
sine phosphorylation with enhanced cell migration and tumor
metastasis [28–32] and inhibition of such processes by prevent-
ing its tyrosine phosphorylation or overexpression of tyrosine
phosphorylation-incompetent mutants [28,29]. Furthermore,
expression of this defective mutant in host cells causes reduc-
tion in Cryptosporidium invasion [33]. As more and more tar-
gets or complexes of cortactin are being identiﬁed, many of
the associated processes are shown to be linked to tyrosine
phosphorylation of cortactin, mostly through the Src (Fig.
1). For example, tyrosine-phosphorylated cortactin is enriched
in podosomes [34], the adhesion microdomains of invasive cells
[35], and also at sites of leukocyte adhesion whereby its associ-
ation with E-selectin and intercellular adhesion molecule-1
(ICAM-1) could help stabilize the Src for recruiting other
SH2 domain-containing proteins at the sites of inﬂammation
[36]. For neuronal morphogenesis and diﬀerentiation, cortac-
tin-Src is necessary for N-syndecan-mediated neurite out-
growth upon induction by extracellular matrix-bound
heparin-binding proteins [37]. However, cortactin interaction
with d-catenin, also associated with growth of primary neu-
rites, is accompanied with reduced tyrosine phosphorylation
by Src [38]. On the other hand, cortactin interacts with the
N-cadherin adhesion complex in a tyrosine-independent man-
ner, but its phosphorylation, probably mediated via Fer, is
necessary for strengthening N-cadherin-mediated adhesion
[39]. Others have shown that cortactin and the Rho guanine
nucleotide exchange factor, ephexin, are phosphorylated by
Src after activation of EphA receptor tyrosine kinase to regu-
late the repulsive axon guidance [40]. The role of cortactin
phosphorylation with targets that regulate the post-synapticdensity, endocytosis and tight junction assembly has yet to
be determined.
Tyrosine phosphorylation of cortactin by Src occurs at
tyrosine residues 421, 466, and 482 through a progressive
manner with initial phosphorylation at tyrosine 421 followed
by 466 [34], whereby it attenuates its ability to cross-link F-
actin in vitro [41] and also inhibits its activation on N-
WASP [18]. On the other hand, the extracellular signal-reg-
ulated kinase (Erk) targets cortactin at serine 405 and serine
418 and their phosphorylation facilitates cortactin binding to
N-WASP for actin polymerization [18]. It is not known
whether other serine/threonine kinases such as p21-activated
kinase (PAK) [42], the downstream eﬀector of Rac and
Cdc42 small GTPases, and the protein kinase N-c (PKNc)
[43] would phosphorylate cortactin in the same region. Cort-
actin is constitutively associated with PAK in resting plate-
lets, whereas PAK activation by thrombin disrupts their
binding, probably rendering cortactin to translocate to cell
periphery for lamellipodial spreading [42]. Although cortac-
tin phosphorylation by PAK is associated with its transloca-
tion, it remains unclear whether this is indeed due to the
phosphorylation per se. This is because it has previously
been shown that kinase-active mutant form of PAK1 fails
to cause cortactin translocation, whereas its mutant that is
deﬁcient in binding to Cdc42/Rac but causing membrane
ruﬄing could lead to cortactin translocation [44]. In compar-
ison, cortactin phosphorylation by the Rac-dependent PKNc
(sites also unknown) is accompanied by downregulation of
its ability to bind F-actin in vitro [43], whereas the endothe-
lial cell myosin light-chain kinase (MLCK) associates di-
rectly with cortactin and this interaction reduces
actin polymerization in vitro [45]. Although its ability to
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cortactin-MLCK has been implicated for lung vascular bar-
rier augmentation and endothelial cell remodeling elicited by
sphingosine 1-phosphate [46].
Cortactin tyrosine phosphorylation may also help stabilize
kinase–cortactin association (e.g., Src and Fer kinase [47,48])
and/or providing docking sites for other SH2 domain-contain-
ing proteins such as Crk and Nck [48,49]. The normal physio-
logical functions of their binding are not currently known
except that during Shigella invasion, Src activity is required
for cortactin recruitment to the membrane where it binds di-
rectly to Crk to mediate the bacteria uptake [49].
Disposition of cortactin plays an important role in ensur-
ing its ultimate binding to targets for diﬀerent cellular pro-
cesses, including its modiﬁcation through phosphorylation.This event is regulated by Rho small GTPases [44] and
Rho GTPase-activating protein (BPGAP1 [23]). Cortactin
is normally sequestered in the cytosol as unphosphorylated
proteins and translocates to cortical actin in lamellipodia
upon growth factors stimulation [34]. Cortactin is also trans-
located from cytosol to periphery upon platelet aggregation
and bacterial entry [50,51]. Furthermore, in either Src-
transformed ﬁbroblasts or in human squamous carcinomas
cells overexpressing cortactin, cortactin redistributes into
podosomes [4,52].
Cortactin translocation is required for its tyrosine phosphor-
ylation by Src and this event is in part mediated via Rac activ-
ity and requires its N-terminal domain [34,11]. However,
during the process of translocation, tyrosine phosphorylation
is either not taking place or happens at very low level. This
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cortactin mutant lacking the PRR can still translocate to the
membrane ruﬄes at the cell cortex upon treatment with plate-
let-derived growth factor (PDGF) [11], whereas upon stimula-
tion with thrombopoietin, cortactin is still able to redistribute
to the cytoskeletal fraction of hemapoietic cells pretreated with
Src family kinase inhibitor PP2 [53]. Furthermore, overexpres-
sion of cortactin mutant lacking the major Src phosphoryla-
tion sites or treatment with inhibitors that block MLCK,
Src, Erk and Rho-associated kinase does not aﬀect its translo-
cation induced by shear stress [54]. Consistently, the Helico-
bacter pylori CagA protein causes Src inactivation and
dephosphorylation of cortactin, concomitantly its redistribu-
tion to actin-rich cellular protrusions [55], while cortactin that
accumulates at the actin tail of pathogens is also not tyrosine-
phosphorylated [56]. Several ﬁndings implicate that cortactin
translocation might be mediated by serine/threonine instead
of tyrosine phosphorylation [42,57]. First, cortactin that spon-
taneously relocalizes to the cell periphery at focal contacts with
the matrix is associated with phosphorylation on serine and
threonine residues [57]. Furthermore, cortactin translocates
to actin-ﬁlament ring in lamellae in response to thrombin-
activated PAK [42]. Recently, it was found that a separate
mechanism might exist whereby cortactin interaction with its
SH3 target, BPGAP1, could facilitate its translocation to the
periphery [23]. Since cortactin lacking its SH3 domain is also
suﬃcient to translocate to the periphery upon activation of
Rac pathway [11], there might exist an ‘‘inhibitory’’ system
in the cells where unknown protein(s) binding to cortactin at
its SH3 domain could prevent it from migrating to the periph-
ery. The overexpression of BPGAP1 could have displaced
these unknown factors, thus rendering its translocation [23].4. Mechanism of regulation for cortactin phosphorylation in
actin assembly: the Serine–Tyrosine switch and
mechanochemical feedback control
A proline-rich region is a prospective ligand for SH3, WW
and EVH signaling domains, depending on the context of theirig. 2. The ‘‘SY-switch’’ and mechanochemical model for cortactin functions in actin organization. (A) The role of cortactin in actin organization is
egulated by the reciprocal interplay between the Erk serine/threonine and Src or Fyn/Fer tyrosine kinases exerting as the ‘‘Serine (S)-switch’’ and
Tyrosine (Y)-switch’’, respectively. Erk phosphorylation could regulate the intramolecular interaction or induce conformational change in cortactin
ading to its binding to N-WASP-Arp2/3 complex for actin polymerization. Actin stabilization is likely to render the cortactin less accessible for
hosphorylation, thus helping to sustain the half-life of the F-actin architecture. During the turnover, some signals are required to trigger Fyn/Fer or
rcs ability to act on cortactin. This could further be enhanced through a mechanochemical feedback by the physical state of actin depolymerization,
s evidenced by the induction of cortactin phosphorylation by actin depolymerization agents, latrunculin B or cytochalasin D, or its prevention by F-
ctin stabilizer, jasplakinolide. Upon initial depolymerization, cortactin could become more readily accessible to the action of these kinases, rather
an just stimulating their activities per se. This leads to reinforced cortactin tyrosine phosphorylation and ensuring further actin disassembly.
urthermore, Src activation can also directly nullify the Erk eﬀect (see B). Such an intricate balance of actin organization is important for regulating
ell dynamics, for example, during the process of cell migration (please refer to the text for more details). The + and  sign denotes stimulatory and
hibitory eﬀect, respectively, whereas P sign denotes phosphorylation. ?, unknown signals. (B) Erk and Src diﬀerentially impact on cortactins ability
regulate actin assembly. Cortactin could exist as an inactive form whereby its SH3 domain could form an intramolecular interaction with its
roline-rich region (PRR) thus inhibiting its binding to other cellular targets. Its phosphorylation by Erk within the tandem PPxxP core motifs of
RR could release this inhibition or induce conformational change (denoted by \), leading to its binding to the PRR of N-WASP instead. This,
gether with its F-actin binding and Arp2/3 binding abilities as well as the presence of Cdc42 and PIP2, could help stabilize the structure of
ortactin-N-WASP-Arp2/3 ternary complex and synergistically enhance actin polymerization. However, the tyrosine phosphorylation of cortactin by
rc within and near the PRR deprives its binding to N-WASP by negatively regulating the conformation of the SH3 domain. This phosphorylation
lso reduces F-actin binding or cross-linking ability or promotes cortactin SH3 binding with the MLCK, leading to further inihibition on actin
olymerization. Furthermore, tyrosine-phosphorylation of cortactin via Src facilitates its removal from actin ﬁlament by calpain-mediated
roteolytic cleavage [79]. The actual orientation of N-WASP binding to cortactin is not known; the diagrammatic representation is intended for
larity purposes. + sign denotes stimulatory eﬀect. Abbreviations used: N,N-terminal; C,C-terminal; MLCK, myosin light chain kinase; EVH, Ena
ASP homology; GBD, GTPase binding domain; NTA, N-terminal acidic; WASP, Wiskott–Aldrich syndrome protein; PIP2, phosphatidylinositolF
r
‘‘
le
p
S
a
a
th
F
c
in
to
p
P
to
c
S
a
p
p
c
V
b4,5 bisphosphate; Arp2/3, actin-related protein 2/3; VCA, verprolin homolosurrounding residues [58]. The proline-rich region for the mur-
ine cortactin harbors two minimal SH3 domain binding con-
sensus motifs (PPxxP) that are adjacent to each other,
namely 402-PPASP-406 and 415-PPSSP-419. However, they
do not readily recognize any SH3 domain-containing proteins.
This could be due to a ‘‘close’’ conformation arising from the
intramolecular interaction between this region and its own
SH3 domain at the carboxyl terminus [59]. Martinez-Quiles
et al. [18] recently showed that Erk phosphorylation at the ser-
ine residues S405 and S418 within this pair of PPxxP core mo-
tifs (underlined above) appears to release the inhibition. They
showed that the cortactin phosphorylated by Erk in vitro or a
mimicking S405,418D double mutation enhanced cortactin
binding to N-WASP to an extent comparable to that observed
with its SH3 domain alone. More importantly, the cortactin
SH3 domain becomes accessible for directly binding to N-
WASP, leading to a synergistic activation of Arp2/3 complex
for the actin polymerization in vitro (Fig. 2A and B). Although
this proline-rich region does not strictly concur to the cortactin
SH3 domain binding consensus sequence +PPw PXKP (where
+ and w indicate basic and hydrophobic amino acid residues,
respectively) [60], several other non-conforming proteins have
also been identiﬁed [2,3,23], supporting the likelihood of such
interaction. However, it remains to be conﬁrmed if the SH3
domain of cortactin does indeed interact with its own
proline-rich region and whether Erk activation in vivo could
promote the actin polymerization upon initiating such cortac-
tin–WASP interaction. In the absence of structural data, it is
possible that Erk phosphorylation could also induce a confor-
mational change within the SH3 domain itself to enhance its
interaction with N-WASP. Recently, cortactin has been shown
to be transiently recruited into the endocytic complex consist-
ing of CD2AP, c-Cbl and endophilin upon treatment with epi-
dermal growth factor, EGF. Such EGF-stimulated interaction
also requires cortactin SH3 domain, further supporting that
conformational dependency of this domain could exist in vivo
[24].
In strong contrary to Erk eﬀect, cortactin phosphorylated by
Src fails to interact and activate N-WASP. In fact, it inhibits
the weak activation of N-WASP normally observed for its full-gy, coﬁlin homology, and acidic region; PRR, proline-rich region.
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Erk-phosphorylated cortactin and the S405,418D mutant from
activating N-WASP [18]. The tyrosine residues 421, 466 and
482 located just upstream of the SH3 domain are critical in
imparting this inhibitory eﬀect upon their phosphorylation by
Src. It is believed that they exert diﬀerent mode of conforma-
tional change to the SH3 domain and that inhibits its capacity
to bind and activate N-WASP. Although the recombinant cor-
tactins were prepared upon sequential phosphorylation in vitro,
it would be interesting to assess how serine phosphorylation of
cortactin would aﬀect the tyrosine phosphorylation and vice
versa in vivo.
The integration of chemical and physical cues is important
for the control of cellular responses which are primarily
mediated via the cytoskeletal network. Such mechanochemi-
cal feedback governed by physical states of F-actin and
cytoskeleton signaling proteins has been demonstrated for
c-Abl tyrosine kinase and that ﬁne-tunes its organization
and activity [61]. Indeed, there exists a reciprocal relation-
ship between the polymerization state of actin and cortactin
tyrosine phosphorylation (Fig. 2A). Using latrunculin B
(LB), an F-actin depolymerization agent that sequesters ac-
tin monomers and inhibits it from adding to a ﬁlament,
Fan et al. [62] showed that this agent could induce robust
tyrosine phosphorylation of cortactin at the key tyrosine res-
idues Y421, Y466 and Y482, mediated only by Fyn/Fer ki-
nase pathway but independently of the Src or c-Abl. This
treatment also enhances the association of Fer with cortactin
through both the actin-binding domain and the proline-rich
region of cortactin, while modestly stimulating the Fer ki-
nase activity. Interestingly, the actin-binding domain within
the N-terminus is essential for the eﬃcient phosphorylation
at these residues implying that the actin-binding domain
could be exposed during depolymerization and that could
help recruit or stabilize Fer-cortactin interaction for its sub-
sequent phosphorylation. As observed for the eﬀect by Src,
cortactin phosphorylation by Fer at these three identical
key residues would be expected to reduce its F-actin bun-
dling activity and reduce the activation for N-WASP and
Arp2/3. Consistently, treatment with another depolymeriza-
tion agent cytochalasin D (that binds to the plus end of ac-
tin ﬁlament inhibiting both association and dissociation of
subunits) could also induce cortactin tyrosine phosphoryla-
tion [63]. Furthermore, hypertonicity has been shown to in-
duce actin depolymerization and cortactin phosphorylation
by Fyn/Fer pathway [64]. In contrast, F-actin stabilization
by a polymerizing drug jasplakinolide induces striking accu-
mulation of cortactin to F-actin clusters and prevents osmo-
tic stress-induced tyrosine phosphorylation of cortactin.
However, once the osmotically induced phosphorylation is
attained, this drug fails to reverse this eﬀect [62]. These re-
sults imply that actin stabilization is likely to render the
cortactin less accessible for phosphorylation rather than just
inhibiting the kinase activity. These observations support a
novel reciprocal mechanism whereby the physical state of ac-
tin organization serves as a potential feedback response to
control cortactin phosphorylation during actin remodeling.
Taken together, there exists a concerted mechanism regu-
lating the actin meshwork by the coordination of tyrosine
and serine/threonine kinases, represented by the reciprocal
‘‘Serine–Tyrosine phosphorylation switch’’ or ‘‘SY-switch’’
model as well as its potential coupling to the mechanochem-ical feedback control (Fig. 2A and B). Erk activated by
stimuli such as growth factors will phosphorylate cortactin
and promote its binding and activation of N-WASP, which
together with its nucleation and F-actin bundling activities
lead to synergism in Arp2/3 activation during actin polymer-
ization, bundling and branching. Once incorporated into a
stabilized F-actin meshwork, cortactin becomes less accessi-
ble for Src or Fer phosphorylation. This would help to sus-
tain the half-life of the F-actin architecture. To reduce actin
assembly, Src could in turn be activated, where it exerts its
negative roles through multiple routes. Not only that tyro-
sine phosphorylation of cortactin inhibits cortactin SH3
from interacting with N-WASP, it could instead promote
cortactin SH3 binding with the MLCK. Consistently, it
has been shown that Src phosphorylation on either MLCK
or/and cortactin increases the association of these proteins
[45]. This in turn leads to a reduction in cortactin-
stimulated, Arp2/3-catalyzed actin polymerization (Fig. 2B).
Hence, this sequential reaction catalyzed by both Src and
MLCK could contribute to the downregulation of actin
polymerization. However, it should be noted that the nega-
tive roles of tyrosine-phosphorylated cortactin were mostly
determined using the ‘‘free’’ phospho-cortactin where they
failed to promote de novo molecular assembly necessary
for actin polymerization. No direct evidence is yet available
to conﬁrm whether F-actin-bound cortactin could be phos-
phorylated in situ and that leads to actin destabilization
and disassembly. Therefore, if cortactin in the stabilized F-
actin is indeed less accessible for phosphorylation, it remains
to be seen what other mechanical and chemical signals are
necessary to initiate the ﬁrst step of actin disassembly. Some
of the potential targets could include actin depolymerization
factors/coﬁlin family and actin ﬁlament-associated proteins
[65]. Once F-actin is destabilized, the exposed F-actin bind-
ing region of cortactin would allow its interaction with Fer
for immediate tyrosine phosphorylation. This will further
reinforce the process of depolymerization.
In essence, this reciprocal ‘‘SY-switch’’ allows a constant
amount of cortactin to be recycled throughout the process of
actin remodeling, for example during cell motility. In such a
case, tyrosine phosphorylation of cortactin at the leading edge
could help liberate cortactin which is then dephosphorylated
before being re-incorporated to the rapidly protruding cell
periphery. We envisage that the level of phosphorylated and
non-phosphorylated form of cortactin should be properly reg-
ulated to propagate the actin remodeling. This would also ex-
plain the fact that whereas tyrosine phosphorylation of
cortactin is not required for its peripheral translocation, its
tyrosine phosphorylated form is found to be localized to cell
periphery upon growth factor stimulation and is necessary
for continued cell migration. Consistent with this model is that
overphosphorylation of cortactin (which deprives them of
re-incorporation) is associated with the inhibition of cell
migration [66], whereas phosphorylation-incompetent cortac-
tin mutants (which could halt actin depolymerization) also hin-
der cell migration and metastatsis [28–30].5. Future prospects
Coupled to various cellular functions is the unique domain
architecture of cortactin. The immediate challenges lie on
B.L. Lua, B.C. Low / FEBS Letters 579 (2005) 577–585 583how and when their phosphorylation-prone proline-rich re-
gion and the SH3 domain could distinguish diﬀerent part-
ners for functional (un)coupling at speciﬁc time and space
in vivo. This can be resolved by examining the speciﬁcity
of binding motifs to distinct partners, elucidating their struc-
tural and targeting mechanisms in the context of diﬀerent
isoforms, cell types and physiological environments. Dissect-
ing how tyrosine and serine/threonine kinases drive its dispo-
sition for actin assembly/disassembly under normal,
pathophysiological and pathogenic stimuli, and identifying
other cellular components in cortactin complexes will further
shed light to its multi-faceted role as a molecular scaﬀold.
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